MCM
ROIV icon

MAI Capital Management’s Roivant Sciences ROIV Stock Holding History

MAI Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$204K Buy
5,751
+1,411
+33% +$41.7K ﹤0.01% 1806
2026
Q1 		$120K Buy
4,340
+4,212
+3,291% +$108K ﹤0.01% 1744
2025
Q4 		$2.78K Buy
+128
New +$2.52K ﹤0.01% 3331
2025
Q3 		– Sell
-383
Closed -$4.32K – 4080
2025
Q2 		$4.32K Buy
+383
New +$4.15K ﹤0.01% 3120

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

MAI Capital Management's ROIV Position: Q2 2026 in Review

MAI Capital Management increased its Roivant Sciences (ROIV) stake by 33% in Q2 2026, buying an estimated $41.7K and bringing the position to 5,751 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #1806.

MAI Capital Management first reported a position in ROIV in Q2 2025 and has held it in 4 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • MAI Capital Management held 5,751 shares of Roivant Sciences worth $204K as of Q2 2026.
  • MAI Capital Management bought 1,411 Roivant Sciences shares in Q2 2026, an estimated $41.7K.
  • Roivant Sciences made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #1806 holding.
  • MAI Capital Management first reported a position in Roivant Sciences in Q2 2025 and has held it in 4 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.